Prevention of Hepatitis B in Travelers to Endemic Areas
The latest World Health Organization estimate is that there are about 300 million chronic carriers of hepatitis B virus (HBV) worldwide . Prevalence varies from between less than 1% in western Europe and North America, to 10%–20% in Asia and 7%–15% in parts of Africa [2–5]. Non-immune travellers to countries in areas with a high incidence of hepatitis B who reside in low-incidence countries are therefore at an increased risk of contracting an infection.
KeywordsPassive Immunization Homosexual Male Circulate Antibody Level Annual Attack Rate Recommend Vaccination Schedule
Unable to display preview. Download preview PDF.
- 1.Anonymous (1988) Viral hepatitis. Weekly Epidemiol Rec 63:89–91Google Scholar
- 5.Gesemann M, Amazigo U, Marcus I, Dupasquier I, Staugard F, Scheiermann N (1987) Prevalence of hepatitis B virus markers and Delta antibodies in Nigeria and Botswana. Trop Med Parasitol 38:268–269Google Scholar
- 6.Sansonno DE, Manghisi OG (1987) Auto-antibody to human albumin after vaccination for hepatitis B infection. Ital J Gastroenterol 19:182–183Google Scholar